Summary : Since the invasion of Ukraine, hundreds of companies have announced a pause or withdrawal of businesses in Russia. Drugmakers Eli…
March 2022
-
-
Pharma Science & Research
NICE to improve diagnosis for foetal alcohol spectrum disorder
by adminby adminSummary : Better treatment for conditions experienced by individuals who were exposed to alcohol before birth The National Institute for Health and…
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminby adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
-
CompaniesModernaPatent LitigationPatentsPfizer
Alnylam Files Patent Infringement Lawsuits Against Pfizer, Moderna
by adminby adminSummary : Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc, claiming their multibillion-dollar…
-
Pharma Science & Research
Bill & Melinda Gates Foundation launch initiative for future pandemics
by adminby adminSummary : The initiative will catalyse discovery and early development of antiviral medicines for future pandemics The Novo Nordisk Foundation, Open Philanthropy…
-
Summary : Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Florida for…
-
Summary : –Japanese pharma Eisai has backed away from its 50:50 profit-sharing arrangement with Biogen for troubled Alzheimer’s therapy Aduhelm, handing over…
-
RegulatoryU.S FDA
FDA approves first generic of Symbicort to treat asthma and COPD
by adminby adminSummary : Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol…
-
Summary : The p53 protein protects our cells from cancer and is an interesting target for cancer treatments. The problem is, however,…
-
CompaniesMerck & CoMerger / Acquisition
Merck & Co pens $340m pain drug deal with KCL and Wellcome
by adminby adminSummary Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers…